Beyond Air (XAIR) Projected to Post Earnings on Friday

Beyond Air (NASDAQ:XAIR) is projected to release its Q3 2026 results before the market opens on Friday, February 13th. Analysts expect Beyond Air to post earnings of ($0.54) per share and revenue of $2.1460 million for the quarter. Investors are encouraged to explore the company’s upcoming Q3 2026 earning overview page for the latest details on the call scheduled for Friday, February 13, 2026 at 8:00 AM ET.

Beyond Air (NASDAQ:XAIR) last posted its quarterly earnings data on Monday, November 10th. The company reported ($1.25) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.10) by ($0.15). The company had revenue of $1.82 million for the quarter, compared to analysts’ expectations of $2.54 million. Beyond Air had a negative return on equity of 261.08% and a negative net margin of 632.51%. On average, analysts expect Beyond Air to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Beyond Air Stock Down 4.1%

XAIR opened at $1.05 on Friday. Beyond Air has a twelve month low of $0.67 and a twelve month high of $10.40. The company’s 50-day moving average price is $1.15 and its two-hundred day moving average price is $1.91. The stock has a market cap of $8.37 million, a price-to-earnings ratio of -0.14 and a beta of 0.39. The company has a quick ratio of 3.73, a current ratio of 4.24 and a debt-to-equity ratio of 0.77.

Institutional Investors Weigh In On Beyond Air

Several large investors have recently added to or reduced their stakes in XAIR. Alyeska Investment Group L.P. bought a new position in Beyond Air in the 3rd quarter worth about $1,753,000. Virtu Financial LLC purchased a new position in shares of Beyond Air during the third quarter worth about $48,000. Osaic Holdings Inc. grew its holdings in shares of Beyond Air by 26.4% during the second quarter. Osaic Holdings Inc. now owns 162,560 shares of the company’s stock worth $29,000 after purchasing an additional 34,000 shares in the last quarter. Finally, Geode Capital Management LLC increased its position in shares of Beyond Air by 1.5% in the second quarter. Geode Capital Management LLC now owns 838,319 shares of the company’s stock worth $144,000 after purchasing an additional 12,598 shares during the last quarter. Institutional investors own 31.50% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently commented on XAIR. Weiss Ratings reaffirmed a “sell (e)” rating on shares of Beyond Air in a research report on Monday, December 22nd. Rodman & Renshaw assumed coverage on Beyond Air in a report on Tuesday, January 20th. They issued a “buy” rating for the company. Finally, D. Boral Capital reiterated a “buy” rating and set a $11.00 price objective on shares of Beyond Air in a research note on Wednesday, January 21st. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Beyond Air currently has a consensus rating of “Moderate Buy” and a consensus price target of $11.00.

Beyond Air Company Profile

Beyond Air, Inc is a clinical-stage medical technology company focused on the development and commercialization of inhaled nitric oxide (NO) therapy for pulmonary and respiratory diseases. The company’s proprietary LungFit® platform delivers pulsed, low-dose nitric oxide gas through compact, portable devices designed to support treatments in both inpatient and outpatient settings. Beyond Air’s approach leverages NO’s antimicrobial, vasodilatory and anti-inflammatory properties to address a range of unmet needs in respiratory medicine.

The company’s lead candidate, LungFit® PH, is under investigation for the treatment of pulmonary hypertension, with ongoing clinical studies assessing its impact on pulmonary arterial pressure and exercise capacity.